Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Clinical trial NCT05327738 · WITHDRAWN

Trial details

NCT number: NCT05327738
Sponsor: OHSU Knight Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

BCLC Stage B Hepatocellular Carcinoma BCLC Stage C Hepatocellular Carcinoma Locally Advanced Hepatocellular Carcinoma Recurrent Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma

Start date: 2022-12-10
Primary completion: 2027-12-04
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.